Fig. 2From: Left atrial longitudinal strain as a predictor of Cancer therapeutics-related cardiac dysfunction in patients with breast CancerSerial changes in left ventricular ejection fraction (LVEF) (panel A), peak left atrial longitudinal strain (PALS) (panel B), left ventricular global longitudinal strain (LVGLS) in cancer therapeutics-related cardiac dysfunction (CTRCD) group (blue line) and no CTRCD group (red line). CTx, chemotherapy. Statistically significant differences are marked by asterisks (*)Back to article page